Get the Stockscreener App
0.46
2.79%
0.0125
After Hours:
.47
0.010
+2.17%
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.46, with a volume of 2.21M.
It is up +2.79% in the last 24 hours and up +17.59% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.4475
Open:
$0.45
24h Volume:
2.21M
Relative Volume:
1.10
Market Cap:
$22.08M
Revenue:
-
Net Income/Loss:
$-37.65M
P/E Ratio:
-0.2754
EPS:
-1.67
Net Cash Flow:
$-24.14M
1W Performance:
+0.79%
1M Performance:
+17.59%
6M Performance:
-75.40%
1Y Performance:
-43.77%
1-Day Range:
$0.4323
$0.4799
1-Week Range:
$0.401
$0.4799
52-Week Range:
$0.30
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.46 | 30.43M | 0 | -37.65M | -24.14M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
How to forecast Reviva Pharmaceuticals Holdings Inc. trends using time seriesScalable Strategy with Chart Confirmation - Newser
What to expect from Reviva Pharmaceuticals Holdings Inc. Equity Warrant in the next 30 daysReal-Time AI Sentiment and Price Forecast - Newser
Why Reviva Pharmaceuticals Holdings Inc. Equity Warrant is moving todayWatchlist Summary for Active Day Traders - Newser
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant recover in the next quarterFree Weekly Return Pick Forecast Reports - Newser
Building trade automation scripts for Reviva Pharmaceuticals Holdings Inc. Equity WarrantReal Trader Watchlist with Entry Targets - Newser
Reviva Pharmaceuticals Holdings Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
How many analysts rate Reviva Pharmaceuticals Holdings Inc. as a “Buy”Discover high-impact stocks for your portfolio - Jammu Links News
Should I hold or sell Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock in 2025Track top-performing stocks in real-time - Jammu Links News
What are Reviva Pharmaceuticals Holdings Inc. company’s key revenue driversFree Investment Timing Strategies - Jammu Links News
How volatile is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock compared to the marketCapitalize on momentum-driven investment opportunities - Jammu Links News
What makes Reviva Pharmaceuticals Holdings Inc. stock price move sharplyUnprecedented profit potential - Jammu Links News
What are the latest earnings results for Reviva Pharmaceuticals Holdings Inc.Build wealth with steady, reliable stocks - Jammu Links News
How strong is Reviva Pharmaceuticals Holdings Inc. company’s balance sheetHigh-yield market plays - Jammu Links News
Is Reviva Pharmaceuticals Holdings Inc. a good long term investmentCapitalize on strong market momentum - Jammu Links News
What institutional investors are buying Reviva Pharmaceuticals Holdings Inc. stockOutstanding capital growth - Jammu Links News
What is Reviva Pharmaceuticals Holdings Inc. company’s growth strategyFree Buy/Sell Signal Notifications - Jammu Links News
Is it the right time to buy Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockInvest smarter with daily market updates - Jammu Links News
What drives Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock priceGet alerts on the hottest market movers - Jammu Links News
Published on: 2025-08-03 11:56:29 - Jammu Links News
How does Reviva Pharmaceuticals Holdings Inc. compare to its industry peersSuperior stock selection - Jammu Links News
Should I hold or sell Reviva Pharmaceuticals Holdings Inc. stock in 2025Capitalize on fast-growing investment opportunities - Jammu Links News
Is Reviva Pharmaceuticals Holdings Inc. a growth stock or a value stockHigh-performance investment picks - Jammu Links News
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant a growth stock or a value stockAccess daily stock market expert updates - jammulinksnews.com
Published on: 2025-08-03 01:32:47 - jammulinksnews.com
What are the technical indicators suggesting about Reviva Pharmaceuticals Holdings Inc.AI Powered Target Finder For Consistent Profits - Jammu Links News
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant Outperform Peers After Recent PullbackDaily Smart Money Movement Monitor Activated - beatles.ru
Published on: 2025-07-29 04:00:41 - metal.it
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs during market volatilityConservative Entry for High Return Setup Backed - metal.it
Why Reviva Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionLow Volatility Stable Growth Picks Rank High - metal.it
Is it the right time to buy Reviva Pharmaceuticals Holdings Inc. stockFinancial News Opportunities That Work - Jammu Links News
How does Reviva Pharmaceuticals Holdings Inc. Equity Warrant generate profit in a changing economyExplosive capital appreciation - Jammu Links News
New Product Launches: Will They Boost Reviva Pharmaceuticals Holdings Inc. Stock in 2025Proven Return Strategy Execution - metal.it
What is the risk reward ratio of investing in Reviva Pharmaceuticals Holdings Inc. stockDiscover the fastest growing stocks today - Jammu Links News
What are Reviva Pharmaceuticals Holdings Inc. Equity Warrant company’s key revenue driversMarket-crushing profits - Jammu Links News
How many analysts rate Reviva Pharmaceuticals Holdings Inc. Equity Warrant as a “Buy”Proven strategies for superior portfolio growth - Jammu Links News
Published on: 2025-07-28 02:35:06 - jammulinksnews.com
Why is Reviva Pharmaceuticals Holdings Inc. stock attracting strong analyst attentionExceptional return forecasts - jammulinksnews.com
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
3.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):